However, DTA-1 significantly augmented the activation of those cells that did traffic to tumor, leading to enhanced effector function (IFN-γ secretion following gp100 peptide re-stimulation) activation (CD44hiCD62Llo phenotype), and proliferation (as measured by CFSE dilution) (Figure 3C). This evidence concerns the gene IFNG and neoplasm.